These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30254421)

  • 1. In vitro and in vivo evaluation of cephalosporins for the treatment of Lyme disease.
    Pothineni VR; Parekh MB; Babar MM; Ambati A; Maguire P; Inayathullah M; Kim KM; Tayebi L; Potula HS; Rajadas J
    Drug Des Devel Ther; 2018; 12():2915-2921. PubMed ID: 30254421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31.
    Pothineni VR; Potula HSK; Ambati A; Mallajosyula VVA; Sridharan B; Inayathullah M; Ahmed MS; Rajadas J
    Sci Rep; 2020 Mar; 10(1):3798. PubMed ID: 32123189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of short-course ceftriaxone therapy for Borrelia burgdorferi infection in C3H mice.
    Pavia C; Inchiosa MA; Wormser GP
    Antimicrob Agents Chemother; 2002 Jan; 46(1):132-4. PubMed ID: 11751123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility of Borrelia burgdorferi isolates to three antibiotics commonly used for treating equine Lyme disease.
    Caol S; Divers T; Crisman M; Chang YF
    BMC Vet Res; 2017 Sep; 13(1):293. PubMed ID: 28962614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents.
    Johnson RC; Kodner CB; Jurkovich PJ; Collins JJ
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2133-6. PubMed ID: 2073103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of an evernimicin (SCH27899) in vitro and in an animal model of Lyme disease.
    Pavia CS; Wormser GP; Nowakowski J; Cacciapuoti A
    Antimicrob Agents Chemother; 2001 Mar; 45(3):936-7. PubMed ID: 11181384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of new drug candidates against Borrelia burgdorferi using high-throughput screening.
    Pothineni VR; Wagh D; Babar MM; Inayathullah M; Solow-Cordero D; Kim KM; Samineni AV; Parekh MB; Tayebi L; Rajadas J
    Drug Des Devel Ther; 2016; 10():1307-22. PubMed ID: 27103785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro and in-vivo antibiotic susceptibilities of Lyme disease Borrelia isolated in China.
    Li M; Masuzawa T; Wang J; Kawabata M; Yanagihara Y
    J Infect Chemother; 2000 Mar; 6(1):65-7. PubMed ID: 11810535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidases from Borrelia burgdorferi: Antibiotic targets for Lyme disease.
    Cornell KA; Knippel RJ; Cortright GR; Fonken M; Guerrero C; Hall AR; Mitchell KA; Thurston JH; Erstad P; Tao A; Xu D; Parveen N
    Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129455. PubMed ID: 31669585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying Vancomycin as an Effective Antibiotic for Killing Borrelia burgdorferi.
    Wu X; Sharma B; Niles S; O'Connor K; Schilling R; Matluck N; D'Onofrio A; Hu LT; Lewis K
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126963
    [No Abstract]   [Full Text] [Related]  

  • 11. Investigating disease severity in an animal model of concurrent babesiosis and Lyme disease.
    Bhanot P; Parveen N
    Int J Parasitol; 2019 Feb; 49(2):145-151. PubMed ID: 30367867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative molecular analyses of Borrelia burgdorferi sensu stricto strains B31 and N40D10/E9 and determination of their pathogenicity.
    Chan K; Awan M; Barthold SW; Parveen N
    BMC Microbiol; 2012 Jul; 12():157. PubMed ID: 22846633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eradication of Biofilm-Like Microcolony Structures of Borrelia burgdorferi by Daunomycin and Daptomycin but not Mitomycin C in Combination with Doxycycline and Cefuroxime.
    Feng J; Weitner M; Shi W; Zhang S; Zhang Y
    Front Microbiol; 2016; 7():62. PubMed ID: 26903956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-Related Differential Stimulation of Immune Response by
    Djokic V; Primus S; Akoolo L; Chakraborti M; Parveen N
    Front Immunol; 2018; 9():2891. PubMed ID: 30619263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of effectiveness of cefovecin, doxycycline, and amoxicillin for the treatment of experimentally induced early Lyme borreliosis in dogs.
    Wagner B; Johnson J; Garcia-Tapia D; Honsberger N; King V; Strietzel C; Hardham JM; Heinz TJ; Marconi RT; Meeus PF
    BMC Vet Res; 2015 Jul; 11():163. PubMed ID: 26205247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of new compounds with high activity against stationary phase Borrelia burgdorferi from the NCI compound collection.
    Feng J; Shi W; Zhang S; Zhang Y
    Emerg Microbes Infect; 2015 Jun; 4(6):e31. PubMed ID: 26954881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Background Amplifies the Effect of Immunodeficiency in Antibiotic Efficacy Against Borrelia burgdorferi.
    Sharma B; McCarthy JE; Freliech CA; Clark MM; Hu LT
    J Infect Dis; 2021 Jul; 224(2):345-350. PubMed ID: 33216133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of bbe02 by Insertion of a Luciferase Gene Increases Transformation Efficiency of Borrelia burgdorferi and Allows Live Imaging in Lyme Disease Susceptible C3H Mice.
    Chan K; Alter L; Barthold SW; Parveen N
    PLoS One; 2015; 10(6):e0129532. PubMed ID: 26069970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo activities of ceftriaxone and vancomycin against Borrelia spp. in the mouse brain and other sites.
    Kazragis RJ; Dever LL; Jorgensen JH; Barbour AG
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2632-6. PubMed ID: 8913478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal pattern of Borrelia burgdorferi p21 expression in ticks and the mammalian host.
    Das S; Barthold SW; Giles SS; Montgomery RR; Telford SR; Fikrig E
    J Clin Invest; 1997 Mar; 99(5):987-95. PubMed ID: 9062357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.